{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:27:42Z","timestamp":1762421262808,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T00:00:00Z","timestamp":1585094400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000199","name":"U.S. Department of Agriculture","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000199","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005825","name":"National Institute of Food and Agriculture","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005825","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.omtm.2020.03.026","type":"journal-article","created":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T19:56:37Z","timestamp":1585598197000},"page":"731-738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["EPPIC (Efficient Purification by Parental Inducer Constraint) Platform for Rapid Generation of Recombinant Vaccinia Viruses"],"prefix":"10.1016","volume":"17","author":[{"given":"Brittany","family":"Jasperse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin M.","family":"O\u2019Connell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo H.","family":"Verardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2020.03.026_bib1","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/infdis\/142.4.636","article-title":"A reality in our time--certification of the global eradication of smallpox","volume":"142","author":"Wehrle","year":"1980","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.omtm.2020.03.026_bib2","doi-asserted-by":"crossref","first-page":"961","DOI":"10.4161\/hv.21080","article-title":"A vaccinia virus renaissance: new vaccine and immunotherapeutic uses after smallpox eradication","volume":"8","author":"Verardi","year":"2012","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.omtm.2020.03.026_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.virusres.2013.12.033","article-title":"Antibiotic-dependent expression of early transcription factor subunits leads to stringent control of vaccinia virus replication","volume":"181","author":"Hagen","year":"2014","journal-title":"Virus Res."},{"key":"10.1016\/j.omtm.2020.03.026_bib4","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1128\/jvi.64.6.3108-3111.1990","article-title":"Transient dominant selection of recombinant vaccinia viruses","volume":"64","author":"Falkner","year":"1990","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2020.03.026_bib5","doi-asserted-by":"crossref","first-page":"14926","DOI":"10.1073\/pnas.1112149108","article-title":"Recombinant Rift Valley fever vaccines induce protective levels of antibody in baboons and resistance to lethal challenge in mice","volume":"108","author":"Papin","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2020.03.026_bib6","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2144\/000113667","article-title":"Use of a negative selectable marker for rapid selection of recombinant vaccinia virus","volume":"50","author":"White","year":"2011","journal-title":"Biotechniques"},{"key":"10.1016\/j.omtm.2020.03.026_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jviromet.2008.10.026","article-title":"Marker gene swapping facilitates recombinant Modified Vaccinia Virus Ankara production by host-range selection","volume":"156","author":"Di Lullo","year":"2009","journal-title":"J.\u00a0Virol. Methods"},{"key":"10.1016\/j.omtm.2020.03.026_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jviromet.2009.09.016","article-title":"The combination of marker gene swapping and fluorescence-activated cell sorting improves the efficiency of recombinant modified vaccinia virus Ankara vaccine production for human use","volume":"163","author":"Di Lullo","year":"2010","journal-title":"J.\u00a0Virol. Methods"},{"key":"10.1016\/j.omtm.2020.03.026_bib9","doi-asserted-by":"crossref","first-page":"e24643","DOI":"10.1371\/journal.pone.0024643","article-title":"A selectable and excisable marker system for the rapid creation of recombinant poxviruses","volume":"6","author":"Rintoul","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2020.03.026_bib10","doi-asserted-by":"crossref","first-page":"15035","DOI":"10.1038\/mtm.2015.35","article-title":"A marker-free system for highly efficient construction of vaccinia virus vectors using CRISPR Cas9","volume":"2","author":"Yuan","year":"2015","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2020.03.026_bib11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.omtm.2017.09.007","article-title":"Rapid Generation of Multiple Loci-Engineered Marker-free Poxvirus and Characterization of a Clinical-Grade Oncolytic Vaccinia Virus","volume":"7","author":"Guo","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2020.03.026_bib12","doi-asserted-by":"crossref","first-page":"15407","DOI":"10.1073\/pnas.1314483110","article-title":"Safety mechanism assisted by the repressor of tetracycline (SMART) vaccinia virus vectors for vaccines and therapeutics","volume":"110","author":"Grigg","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2020.03.026_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1475-2859-12-67","article-title":"A single mutation in the core domain of the lac repressor reduces leakiness","volume":"12","author":"Gatti-Lafranconi","year":"2013","journal-title":"Microb. Cell Fact."},{"key":"10.1016\/j.omtm.2020.03.026_bib14","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1073\/pnas.80.22.6785","article-title":"A perfectly symmetric lac operator binds the lac repressor very tightly","volume":"80","author":"Sadler","year":"1983","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2020.03.026_bib15","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.2144\/97236st07","article-title":"Compact, synthetic, vaccinia virus early\/late promoter for protein expression","volume":"23","author":"Chakrabarti","year":"1997","journal-title":"Biotechniques"},{"key":"10.1016\/j.omtm.2020.03.026_bib16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev.mi.48.100194.002021","article-title":"Mechanisms underlying expression of Tn10 encoded tetracycline resistance","volume":"48","author":"Hillen","year":"1994","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.omtm.2020.03.026_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230711","article-title":"Replication-inducible vaccinia virus vectors with enhanced safety in vivo","volume":"15","author":"O\u2019Connell","year":"2020","journal-title":"PLoS One"}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120300565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120300565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:23:35Z","timestamp":1762421015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050120300565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":17,"alternative-id":["S2329050120300565"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2020.03.026","relation":{},"ISSN":["2329-0501"],"issn-type":[{"type":"print","value":"2329-0501"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EPPIC (Efficient Purification by Parental Inducer Constraint) Platform for Rapid Generation of Recombinant Vaccinia Viruses","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2020.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s).","name":"copyright","label":"Copyright"}]}}